Villeneuve-d'Ascq, France · Founded 2020 · Privately Held (backing)
Operator of a biotechnology platform intended to treat resistant tumors using proprietary photosensitizing molecules paired with advanced laser light technologies. Hemerion Therapeutics is based in Villeneuve-d'Ascq, France and was founded in 2020. Its last reported valuation was $26.2 million in May 2025. It has raised $14.2 million.
These 9 firms already write checks for companies like Hemerion Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
